| molecular function |
|---|
| | GO:0005524 | | ATP binding | | Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
| | GO:0016301 | | kinase activity | | Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule. |
| | GO:0000166 | | nucleotide binding | | Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose. |
| | GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| | GO:0034236 | | protein kinase A catalytic subunit binding | | Interacting selectively and non-covalently with one or both of the catalytic subunits of protein kinase A. |
| | GO:0004672 | | protein kinase activity | | Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP. |
| | GO:0004674 | | protein serine/threonine kinase activity | | Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate. |
| | GO:0050321 | | tau-protein kinase activity | | Catalysis of the reaction: ATP + tau-protein = ADP + O-phospho-tau-protein. |
| | GO:0016740 | | transferase activity | | Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2. |
| biological process |
|---|
| | GO:0036498 | | IRE1-mediated unfolded protein response | | A series of molecular signals mediated by the endoplasmic reticulum stress sensor IRE1 (Inositol-requiring transmembrane kinase/endonuclease). Begins with activation of IRE1 in response to endoplasmic reticulum (ER) stress, and ends with regulation of a downstream cellular process, e.g. transcription. One target of activated IRE1 is the transcription factor HAC1 in yeast, or XBP1 in mammals; IRE1 cleaves an intron of a mRNA coding for HAC1/XBP1 to generate an activated HAC1/XBP1 transcription factor, which controls the up regulation of UPR-related genes. At least in mammals, IRE1 can also signal through additional intracellular pathways including JNK and NF-kappaB. |
| | GO:0016055 | | Wnt signaling pathway | | The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell and ending with a change in cell state. |
| | GO:0005975 | | carbohydrate metabolic process | | The chemical reactions and pathways involving carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y. Includes the formation of carbohydrate derivatives by the addition of a carbohydrate residue to another molecule. |
| | GO:0003214 | | cardiac left ventricle morphogenesis | | The process in which the left cardiac ventricle is generated and organized. |
| | GO:0032869 | | cellular response to insulin stimulus | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms. |
| | GO:0036016 | | cellular response to interleukin-3 | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-3 stimulus. |
| | GO:0099565 | | chemical synaptic transmission, postsynaptic | | The part of synaptic transmission occurring in the post-synapse: a signal transduction pathway consisting of neurotransmitter receptor activation and its effects on postsynaptic membrane potential and the ionic composition of the postsynaptic cytosol. |
| | GO:0007212 | | dopamine receptor signaling pathway | | The series of molecular signals generated as a consequence of a dopamine receptor binding to one of its physiological ligands. |
| | GO:0097192 | | extrinsic apoptotic signaling pathway in absence of ligand | | A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with withdrawal of a ligand from a cell surface receptor, and ends when the execution phase of apoptosis is triggered. |
| | GO:0005977 | | glycogen metabolic process | | The chemical reactions and pathways involving glycogen, a polydisperse, highly branched glucan composed of chains of D-glucose residues in alpha-(1->4) glycosidic linkage, joined together by alpha-(1->6) glycosidic linkages. |
| | GO:0008286 | | insulin receptor signaling pathway | | The series of molecular signals generated as a consequence of the insulin receptor binding to insulin. |
| | GO:0032007 | | negative regulation of TOR signaling | | Any process that stops, prevents, or reduces the frequency, rate or extent of TOR signaling. |
| | GO:0010905 | | negative regulation of UDP-glucose catabolic process | | Any process that decreases the rate, frequency or extent of UDP-glucose catabolism. UDP-glucose catabolic processes are the chemical reactions and pathways resulting in the breakdown of UDP-glucose, uridinediphosphoglucose, a substance composed of glucose in glycosidic linkage with uridine diphosphate. |
| | GO:0090090 | | negative regulation of canonical Wnt signaling pathway | | Any process that decreases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. |
| | GO:0061052 | | negative regulation of cell growth involved in cardiac muscle cell development | | Any process that decreases the rate, frequency, or extent of the growth of a cardiac muscle cell, where growth contributes to the progression of the cell over time from its initial formation to its mature state. |
| | GO:0046325 | | negative regulation of glucose import | | Any process that stops, prevents, or reduces the frequency, rate or extent of the import of the hexose monosaccharide glucose into a cell or organelle. |
| | GO:2000466 | | negative regulation of glycogen (starch) synthase activity | | Any process that stops, prevents or reduces the frequency, rate or extent of glycogen (starch) synthase activity. |
| | GO:0045719 | | negative regulation of glycogen biosynthetic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of glycogen. |
| | GO:1904227 | | negative regulation of glycogen synthase activity, transferring glucose-1-phosphate | | Any process that stops, prevents or reduces the frequency, rate or extent of glycogen synthase activity, transferring glucose-1-phosphate. |
| | GO:0046627 | | negative regulation of insulin receptor signaling pathway | | Any process that stops, prevents, or reduces the frequency, rate or extent of insulin receptor signaling. |
| | GO:0009968 | | negative regulation of signal transduction | | Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction. |
| | GO:2000077 | | negative regulation of type B pancreatic cell development | | Any process that stops, prevents, or reduces the frequency, rate or extent of pancreatic B cell development. |
| | GO:0007399 | | nervous system development | | The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state. |
| | GO:0016310 | | phosphorylation | | The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide. |
| | GO:0071879 | | positive regulation of adrenergic receptor signaling pathway | | Any process that activates or increases the frequency, rate or extent of the adrenergic receptor protein signaling pathway. An adrenergic receptor signaling pathway is the series of molecular signals generated as a consequence of an adrenergic receptor binding to one of its physiological ligands. |
| | GO:0030819 | | positive regulation of cAMP biosynthetic process | | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of the nucleotide cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate). |
| | GO:2000467 | | positive regulation of glycogen (starch) synthase activity | | Any process that activates or increases the frequency, rate or extent of glycogen (starch) synthase activity. |
| | GO:0045823 | | positive regulation of heart contraction | | Any process that activates or increases the frequency, rate or extent of heart contraction. |
| | GO:1901030 | | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | | Any process that activates or increases the frequency, rate or extent of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway. |
| | GO:0045732 | | positive regulation of protein catabolic process | | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds. |
| | GO:1903955 | | positive regulation of protein targeting to mitochondrion | | Any process that activates or increases the frequency, rate or extent of protein targeting to mitochondrion. |
| | GO:0043161 | | proteasome-mediated ubiquitin-dependent protein catabolic process | | The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome. |
| | GO:0006468 | | protein phosphorylation | | The process of introducing a phosphate group on to a protein. |
| | GO:1903146 | | regulation of mitophagy | | Any process that modulates the frequency, rate or extent of mitochondrion degradation (mitophagy). |
| | GO:0003073 | | regulation of systemic arterial blood pressure | | The process that modulates the force with which blood travels through the systemic arterial circulatory system. The process is controlled by a balance of processes that increase pressure and decrease pressure. |
| cellular component |
|---|
| | GO:0030877 | | beta-catenin destruction complex | | A cytoplasmic protein complex containing glycogen synthase kinase-3-beta (GSK-3-beta), the adenomatous polyposis coli protein (APC), and the scaffolding protein axin, among others; phosphorylates beta-catenin, targets it for degradation by the proteasome. |
| | GO:0005829 | | cytosol | | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| | GO:0005739 | | mitochondrion | | A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration. |
| | GO:0098794 | | postsynapse | | The part of a synapse that is part of the post-synaptic cell. |
Description
